OncBioMune Receives Patent Protecting Novel Cancer Vaccine in Mexico

June 21st, 2017|0 Comments

BATON ROUGE, LA—(June 21, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies, [...]

OncBioMune Awarded Patent for ProscaVax in Japan

June 20th, 2017|0 Comments

BATON ROUGE, LA--(June 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies, [...]

OncBioMune Acquires Norepinefrine for Low Blood Pressure and Heart Failure in Mexico from Teva Pharmaceuticals Mexico

June 19th, 2017|0 Comments

MEXICO CITY, MEXICO--(June 19, 2017) - OncBioMune México, S.A. De C.V., (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted [...]

OncBioMune, AqVida add additional drugs to distribution agreement (Paclitaxel and Oxaliplatin)

June 15th, 2017|0 Comments

BATON ROUGE, LA--(June 15, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]

OncBioMune Protects ProscaVax Cancer Treatment Technology in Hong Kong

June 7th, 2017|0 Comments

BATON ROUGE, LA--(June 07, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies [...]

OncBioMune’s Andfrt(R) Shown in Clinical Trial to Improve Sperm Count and Mobility

June 6th, 2017|0 Comments

BATON ROUGE, LA--(June 06, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies [...]

Protocol Submitted to FDA for Phase 2 Clinical Trial of ProscaVax as Immunotherapy for Early-Stage Prostate Cancer

June 1st, 2017|0 Comments

BATON ROUGE, LA—(June 01, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of targeted cancer [...]

OncBioMune Reports Record Monthly Sales for Bekunis(R) in May

May 31st, 2017|0 Comments

BATON ROUGE, LA--(May 31, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of targeted cancer [...]

OncBioMune Receives Approval for Male Fertility Product in Mexico

May 30th, 2017|0 Comments

BATON ROUGE, LA--(May 30, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]

OncBioMune CMO Begins Formulation Work on Tretinoin for Acute Promyelocytic Leukemia

May 23rd, 2017|0 Comments

BATON ROUGE, LA--(May 23, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]

OncBioMune Provides Corporate Update, Nearly 50 Drug Candidates in Pipeline or Being Negotiated

May 9th, 2017|0 Comments

BATON ROUGE, LA--(May 9, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP)("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of targeted cancer therapies and [...]

OncBioMune Completes Enrollment in Phase 1 Trial of ProscaVax for Prostate Cancer

May 3rd, 2017|0 Comments

BATON ROUGE, LA--(May 03, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of targeted cancer [...]

OncBioMune, AqVida Partner for Commercializing Cancer and Other Generic Drugs in Mexico

April 26th, 2017|0 Comments

Companies Negotiating Joint Venture for Clinical Development of ProscaVax for Prostate Cancer in Europe BATON ROUGE, LA--(April 26, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or [...]

OncBioMune Licenses Tretinoin for the Treatment of Acute Promyelocytic Leukemia Throughout Mexico, Central and Latin America

April 20th, 2017|0 Comments

BATON ROUGE, LA--(April 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]

OncBioMune Prepares Submission Seeking Marketing Approval for Anti-D Immunoglobulin in Mexico

April 18th, 2017|0 Comments

BATON ROUGE, LA--(April 18, 2017) - OncBioMune Pharmaceuticals, Inc. (OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products [...]

OncBioMune and Gem Pharmaceuticals Finalizing Partnership Terms to Develop New Cancer Drug for Mexico, Central and Latin America Markets

March 30th, 2017|0 Comments

BATON ROUGE, LA--(March 30, 2017) - OncBioMune Pharmaceuticals, Inc. (OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products [...]

OncBioMune Sales of Bekunis® and Cirkused® Exceed Forecast by 164 Percent in First Six Months on Market

March 27th, 2017|0 Comments

BATON ROUGE, LA--(March 27, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]

OncBioMune Announces Term Sheet to Acquire Norepinefrine from Teva Pharmaceuticals in Mexico

March 20th, 2017|0 Comments

BATON ROUGE, LA--(March 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]

OncBioMune Announces Term Sheet with EOC Pharma for Development of Telatinib

March 14th, 2017|0 Comments

BATON ROUGE, LA--(March 14, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]

OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network

March 13th, 2017|0 Comments

BATON ROUGE, LA--(March 13, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer [...]